Back to home

How does PCV20 compare to PCV13 and PPSV23?

Updated by HEALTHIERSG

PCV20, which has been registered for use with the HSA since 30 November 2022, provides a broader coverage of pneumococcal strains. Studies have shown that the vaccine induces antibody levels comparable to those induced by PCV13 or PPSV23. In addition, vaccination with PCV20 can be completed as a single dose regimen.

Topics:

Healthier SG Vaccinations

Related questions

What are the updated pneumococcal vaccination recommendations under the NAIS?

healthiersg
3

Will the older pneumococcal vaccines (PCV13 and PPSV23) still be available in the NAIS?

healthiersg
1

Do I need another dose of PCV20 in future for prolonged protection or is this a one-time dose?

healthiersg
1

If I have started on the PCV13/PPSV23 regimen, should I switch to PCV20?

healthiersg

Need more help?

Describe your issues to us.

Contact us